logo VRX

Delayed Methotrexate clearance due to acute kidney injury is an oncologic emergency1-3

Only Voraxaze® (glucarpidase) can lower methotrexate (MTX) levels by ≥97% in 15 minutes, reducing the risk for severe toxicities and death. <sup>1,3-5</sup>

Act Early

Early treatment with Voraxaze resulted in significantly lower rates of toxicity and mortality.1,6

View Efficacy

Act With Confidence

Review hospitalization outcomes based on actual Medicare claims data for patients treated with Voraxaze.7

View Hospital Outcomes With Voraxaze

MTX Monitoring Tool

See if your patient is clearing MTX as expected.
 

Learn How to Use MTXPK.org
Why Stock Voraxaze
Voraxaze lowers plasma MTX 
by ≥97% in 15 minutes.<sup>5</sup>
View Efficacy
High-Dose Methotrexate (HDMTX) Toxicity and Acute Kidney Injury
Keep Voraxaze top-of-mind when treating with HDMTX.
Learn About HDMTX Toxicity
Identify and Treat Delayed MTX Clearance Early
Consensus Guidelines recommend early use of Voraxaze.<sup>2</sup>
View Guidelines